Concepedia

Vladimir Coric

VC

Statistics

Publications

61

Citations

5.1K

H-Index

33

Active since

1998

Affiliations

Biohaven Pharmaceuticals (United States)(Current)

Yale University

Albert Einstein College of Medicine

University of California, Los Angeles

Bristol-Myers Squibb (United States)

Vladimir Coric is an author at Biohaven Pharmaceuticals (United States) specializing in medicine, psychiatry, and social sciences.

Top concepts

Publications per year

1998–2024

61

Publications

61

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

Robert Croop, Peter J. Goadsby, David Stock et al. · The Lancet · 2019 · 379 citations

, , +5

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

Richard B. Lipton, Robert Croop, Elyse Stock et al. · New England Journal of Medicine · 2019 · 379 citations · Full text

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 363 citations

Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture

Lea K. Davis, Dongmei Yu, Clare L. Keenan et al. · PLoS Genetics · 2013 · 341 citations · Full text

, , +22

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Robert Croop, Richard B. Lipton, David Kudrow et al. · The Lancet · 2020 · 334 citations

, , +7

1–5 of 61